Healthcare -
Biotechnology - NASDAQ - FR
$ 1.69
1.2 %
$ 142 M
Market Cap
-3.93
P/E
IPHA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities IPHA - Innate Pharma S.A.
20.6 M
LAST VALUE
394.96%
2 YEAR CAGR
-3.20%
5 YEAR CAGR
37.14%
10 YEAR CAGR